Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 4/2019

Open Access 01-10-2019 | Original Article

Effect of Frequency of Platelet Apheresis on Coagulation Function in Donors: A Prospective Cohort Study

Authors: Qing Feng, Faming Zhu, Chunyan Li, Beijie Guo, Jun Ye, Jiangtian Chen

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2019

Login to get access

Abstract

The maximum number of plateletpheresis donation was permitted up to 24 times every year for each donor in China. This study was investigated the effect of donation frequency on coagulation function of the plateletpheresis donors. A total of 96 plateletpheresis regular donors (splitted into A, B, C groups with 32 donors each group. A was 6–11 times donations, B with 12–17 times and C with 18–24 times) and 32 first time plateletpheresis donors (D group) were analyzed. The coagulation reaction time (R), blood clot formation time (K), α-Angle, normal maximum amplitude (MA) were tested using thromboelastography instrument. Platelet (PLT) count was measured using a hematology analyzer. The ratio of the male to female were 23:9, 24:8, 27:5 and 24:8, the mean age were 40.7 ± 7.6, 39.8 ± 8.3, 40.2 ± 7.9 and 37.0 ± 9.3, and the platelet collection amount were 1.55 ± 0.37 U, 1.58 ± 0.38 U, 1.61 ± 0.33 U and 1.46 ± 0.31 U in the A, B, C, D groups respectively. There were significant difference in the values of the R, K, α-Angle, MA and PLT count between before and after plateletpheresis donation in each group (p < 0.05). However, the values of R, K, α-Angle, MA and PLT count in the before donation were not difference among the A, B, C, D groups (p > 0.05). Similar results were found in the after plateletpheresis donation. The number of the PLT was significantly correlated with the values of the R, K, α-Angle and MA (p < 0.05). However, the frequency of plateletpheresis were not significantly correlated with R, k, α and MA parameters (p > 0.05) using Spearman correlation analysis. The regular donation of apheresis platelets and the frequency of annual blood donation had no adverse effect upon coagulation function of the donors in China.
Literature
1.
go back to reference van der Meer PF (2013) Platelet concentrates, from whole blood or collected by apheresis? Transfus Apher Sci 48(2):129–131CrossRef van der Meer PF (2013) Platelet concentrates, from whole blood or collected by apheresis? Transfus Apher Sci 48(2):129–131CrossRef
2.
go back to reference Ness PM, Braine HG, King KE, Barsasso C, Kennedy SD (1999) Single donor platelets reduce the risk of septic transfusion reactions. Transfusion 39:89CrossRef Ness PM, Braine HG, King KE, Barsasso C, Kennedy SD (1999) Single donor platelets reduce the risk of septic transfusion reactions. Transfusion 39:89CrossRef
3.
go back to reference Despotis GJ, Goodnough LT, Dynis M et al (1999) Adverse events in platelet apheresis donors: a multivariate analysis in a hospital-based program. Vox Sang 77:24–32CrossRef Despotis GJ, Goodnough LT, Dynis M et al (1999) Adverse events in platelet apheresis donors: a multivariate analysis in a hospital-based program. Vox Sang 77:24–32CrossRef
4.
go back to reference Thokala RP, Radhakrishnan K, Anandan A, Panicker VK (2016) Recovery of platelet count among apheresis platelet donors. J Clin Diagn Res 10(12):EC01–EC04PubMedPubMedCentral Thokala RP, Radhakrishnan K, Anandan A, Panicker VK (2016) Recovery of platelet count among apheresis platelet donors. J Clin Diagn Res 10(12):EC01–EC04PubMedPubMedCentral
5.
go back to reference Richa E, Krueger P, Burgstaler EA, Bryant SC, Winters JL (2008) The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts. Transfusion 48(7):1325–1332CrossRef Richa E, Krueger P, Burgstaler EA, Bryant SC, Winters JL (2008) The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts. Transfusion 48(7):1325–1332CrossRef
6.
go back to reference Katz L, Palmer K, McDonnell E, Kabat A (2007) Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors. Transfusion 47:1601–1606CrossRef Katz L, Palmer K, McDonnell E, Kabat A (2007) Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors. Transfusion 47:1601–1606CrossRef
7.
go back to reference da Luz LT, Nascimento B, Rizoli S (2013) Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation. Scand J Trauma Resusc Emerg Med 21:29CrossRef da Luz LT, Nascimento B, Rizoli S (2013) Thrombelastography (TEG®): practical considerations on its clinical use in trauma resuscitation. Scand J Trauma Resusc Emerg Med 21:29CrossRef
8.
go back to reference Chitlur M, Rivard GE, Lillicrap D, Mann K, Shima M, Young G, Factor VIII, Factor IX, and Rare Coagulation Disorders Subcommittee of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis (2014) Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 12(1):103–106CrossRef Chitlur M, Rivard GE, Lillicrap D, Mann K, Shima M, Young G, Factor VIII, Factor IX, and Rare Coagulation Disorders Subcommittee of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis (2014) Recommendations for performing thromboelastography/thromboelastometry in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost 12(1):103–106CrossRef
9.
go back to reference Whiting D, DiNardo JA (2014) TEG and ROTEM: technology and clinical applications. Am J Hematol 89(2):228–232CrossRef Whiting D, DiNardo JA (2014) TEG and ROTEM: technology and clinical applications. Am J Hematol 89(2):228–232CrossRef
10.
go back to reference Beyan C, Kaptan K, Savasci S et al (2005) Platelet apheresis affects prothrombin time and plasminogen levels in healthy donors. Transfus Apher Sci 33:47–50CrossRef Beyan C, Kaptan K, Savasci S et al (2005) Platelet apheresis affects prothrombin time and plasminogen levels in healthy donors. Transfus Apher Sci 33:47–50CrossRef
11.
go back to reference Akay OM, Akın E, Mutlu F (2007) The effects of plateletpheresis on donor platelet function and coagulation. Transfus Apher Sci 37(1):113–114CrossRef Akay OM, Akın E, Mutlu F (2007) The effects of plateletpheresis on donor platelet function and coagulation. Transfus Apher Sci 37(1):113–114CrossRef
12.
go back to reference Luddington RJ (2005) Thrombelastography/thromboelastometry. Clin Lab Haematol 27:81–89CrossRef Luddington RJ (2005) Thrombelastography/thromboelastometry. Clin Lab Haematol 27:81–89CrossRef
13.
go back to reference Hobson AR, Agarwala RA, Swallow RA et al (2006) Thrombelastography: current clinical applications and its potential role in interventional cardiology. Platelets 17:509–518CrossRef Hobson AR, Agarwala RA, Swallow RA et al (2006) Thrombelastography: current clinical applications and its potential role in interventional cardiology. Platelets 17:509–518CrossRef
14.
go back to reference Johansson PI, Sorensen AM, Larsen CF (2013) Low hemorrhage-related mortality in trauma patients in a level I trauma center employing transfusion packages and early thromboelastography-directed hemostatic resuscitation with plasma and platelets. Transfusion 53(12):3088–3099CrossRef Johansson PI, Sorensen AM, Larsen CF (2013) Low hemorrhage-related mortality in trauma patients in a level I trauma center employing transfusion packages and early thromboelastography-directed hemostatic resuscitation with plasma and platelets. Transfusion 53(12):3088–3099CrossRef
15.
go back to reference Agren Wikman AT, Holmstrom M et al (2013) Thrombelastography (TEG) compared to conventional coagulation tests in surgical patients: a laboratory evalution. Scand J Clin Lab Invest 73(3):214–220CrossRef Agren Wikman AT, Holmstrom M et al (2013) Thrombelastography (TEG) compared to conventional coagulation tests in surgical patients: a laboratory evalution. Scand J Clin Lab Invest 73(3):214–220CrossRef
16.
go back to reference Bolan CD, Greer SE, Cecco SA, Oblitas JM, Rehak NN, Leitman SF (2001) Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 41:1165–1171CrossRef Bolan CD, Greer SE, Cecco SA, Oblitas JM, Rehak NN, Leitman SF (2001) Comprehensive analysis of citrate effects during plateletpheresis in normal donors. Transfusion 41:1165–1171CrossRef
17.
go back to reference Grau K, Vasan SK, Rostgaard K, Bialkowski W, Norda R, Hjalgrim H et al (2017) No association between frequent apheresis donation and risk of fractures: a retrospective cohort analysis from Sweden. Transfusion 57:390–396CrossRef Grau K, Vasan SK, Rostgaard K, Bialkowski W, Norda R, Hjalgrim H et al (2017) No association between frequent apheresis donation and risk of fractures: a retrospective cohort analysis from Sweden. Transfusion 57:390–396CrossRef
18.
go back to reference Zhou Q, Yu X, Cai Y, Liu L (2017) Blood changes in pre- and post-donation platelet function in plateletpheresis donors modifications. Transfus Clin Biol 24:417–421CrossRef Zhou Q, Yu X, Cai Y, Liu L (2017) Blood changes in pre- and post-donation platelet function in plateletpheresis donors modifications. Transfus Clin Biol 24:417–421CrossRef
19.
go back to reference Parker R, Eley KA, Von Kier S et al (2012) Functional fibrinogen to platelet ratio using thromboelastography as a predictive parameter for thrombotic complications following free tissue transfer surgery: a preliminary study. Microsurgery 32:512–519CrossRef Parker R, Eley KA, Von Kier S et al (2012) Functional fibrinogen to platelet ratio using thromboelastography as a predictive parameter for thrombotic complications following free tissue transfer surgery: a preliminary study. Microsurgery 32:512–519CrossRef
20.
go back to reference Yilmaz M, Dikmen T, Sonmez M (2007) Change of coagulation parameters after double plateletpheresis. Transfus Apher Sci 37:161–163CrossRef Yilmaz M, Dikmen T, Sonmez M (2007) Change of coagulation parameters after double plateletpheresis. Transfus Apher Sci 37:161–163CrossRef
21.
go back to reference Lazarus Ellen F, Browning Janet, Norman James et al (2001) Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations. Transfusion 41:756–761CrossRef Lazarus Ellen F, Browning Janet, Norman James et al (2001) Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations. Transfusion 41:756–761CrossRef
22.
go back to reference Petra J, Hergovich N, Homoncik M, Dzirlo L, Horvath M et al (2001) Impaired platelet function among platelet donors. Thromb Haemost 86:880–886CrossRef Petra J, Hergovich N, Homoncik M, Dzirlo L, Horvath M et al (2001) Impaired platelet function among platelet donors. Thromb Haemost 86:880–886CrossRef
23.
go back to reference Boehlen F, Michel M, Reber G, Moerloose P (2001) Analysis of platelet donors function before and after thrombapheresis using the platelet function analyzer PFA-100. Thromb Res 102:49–52CrossRef Boehlen F, Michel M, Reber G, Moerloose P (2001) Analysis of platelet donors function before and after thrombapheresis using the platelet function analyzer PFA-100. Thromb Res 102:49–52CrossRef
Metadata
Title
Effect of Frequency of Platelet Apheresis on Coagulation Function in Donors: A Prospective Cohort Study
Authors
Qing Feng
Faming Zhu
Chunyan Li
Beijie Guo
Jun Ye
Jiangtian Chen
Publication date
01-10-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-019-01130-9

Other articles of this Issue 4/2019

Indian Journal of Hematology and Blood Transfusion 4/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine